Literature DB >> 25591582

P2X7 receptors: role in bone cell formation and function.

Ankita Agrawal1, Alison Gartland2.   

Abstract

The role of the P2X7 receptor (P2X7R) is being explored with intensive interest in the context of normal bone physiology, bone-related diseases and, to an extent, bone cancer. In this review, we cover the current understanding of P2X7R regulation of bone cell formation, function and survival. We will discuss how the P2X7R drives lineage commitment of undifferentiated bone cell progenitors, the vital role of P2X7R activation in bone mineralisation and its relatively unexplored role in osteocyte function. We also review how P2X7R activation is imperative for osteoclast formation and its role in bone resorption via orchestrating osteoclast apoptosis. Variations in the gene for the P2X7R (P2RX7) have implications for P2X7R-mediated processes and we review the relevance of these genetic variations in bone physiology. Finally, we highlight how targeting P2X7R may have therapeutic potential in bone disease and cancer.
© 2015 Society for Endocrinology.

Entities:  

Keywords:  P2X7; apoptosis; bone; cancer; osteoblast; osteoclast

Mesh:

Substances:

Year:  2015        PMID: 25591582     DOI: 10.1530/JME-14-0226

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  23 in total

1.  Expression of P2X7R in breast cancer tissue and the induction of apoptosis by the gene-specific shRNA in MCF-7 cells.

Authors:  Chao Tan; L I Han; Lili Zou; Chunhua Luo; Aihua Liu; Xiejing Sheng; Dee Xi
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  TRPV4 calcium influx controls sclerostin protein loss independent of purinergic calcium oscillations.

Authors:  Katrina M Williams; Jenna M Leser; Nicole R Gould; Humberto C Joca; James S Lyons; Ramzi J Khairallah; Christopher W Ward; Joseph P Stains
Journal:  Bone       Date:  2020-04-06       Impact factor: 4.398

4.  Identification of rs11615992 as a novel regulatory SNP for human P2RX7 by allele-specific expression.

Authors:  Tao Peng; Li Zhong; Jing Gao; Zhu Wan; Wei-Ping Fu; Chang Sun
Journal:  Mol Genet Genomics       Date:  2019-08-13       Impact factor: 3.291

5.  Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue.

Authors:  Marzia Carluccio; Mariachiara Zuccarini; Sihana Ziberi; Patricia Giuliani; Caterina Morabito; Maria A Mariggiò; Maria Teresa Lonardo; Elena Adinolfi; Elisa Orioli; Patrizia Di Iorio; Francesco Caciagli; Renata Ciccarelli
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 6.  P2X receptors.

Authors:  R Alan North
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

Review 7.  Osteocytes and Diabetes: Altered Function of Diabetic Osteocytes.

Authors:  Arancha R Gortázar; Juan A Ardura
Journal:  Curr Osteoporos Rep       Date:  2020-11-13       Impact factor: 5.096

Review 8.  P2X7 receptor: a critical regulator and potential target for breast cancer.

Authors:  Xiaodi Zhu; Qianqian Li; Wei Song; Xiaoxiang Peng; Ronglan Zhao
Journal:  J Mol Med (Berl)       Date:  2021-01-23       Impact factor: 4.599

Review 9.  P2X7Rs: new therapeutic targets for osteoporosis.

Authors:  Haoyun Huang; Yu-Mei He; Miao-Miao Lin; Yanchao Wang; Xiaomei Zhang; Li Liang; Xueling He
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

Review 10.  The cytoskeleton and connected elements in bone cell mechano-transduction.

Authors:  Nicole R Gould; Olivia M Torre; Jenna M Leser; Joseph P Stains
Journal:  Bone       Date:  2021-04-21       Impact factor: 4.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.